Alzheimer's Disease and Glaucoma: Imaging the Biomarkers of Neurodegenerative Disease
2010

Alzheimer's Disease and Glaucoma: Imaging the Biomarkers of Neurodegenerative Disease

Sample size: 172 publication Evidence: moderate

Author Information

Author(s): Denise A. Valenti

Primary Institution: Vision Care, Quincy, MA, USA

Hypothesis

The retrograde loss of nerve fiber layer tissue in the retina and optic nerve may be an early biomarker of Alzheimer's disease.

Conclusion

OCT imaging has demonstrated structural nerve fiber deficits in the eye in early Alzheimer's disease as well as Mild Cognitive Impairment.

Supporting Evidence

  • OCT imaging has shown deficits specific to Alzheimer's disease and mild cognitive impairment.
  • The study found a higher rate of glaucoma among Alzheimer's patients compared to non-AD patients.
  • Imaging technology has evolved to provide higher resolution and faster acquisition times.

Takeaway

Doctors can use special eye scans to find early signs of Alzheimer's disease by looking at the nerves in the eye.

Methodology

The study utilized Optical Coherence Tomography (OCT) to assess nerve fiber layer thickness in participants with Alzheimer's disease and age-matched controls.

Limitations

The relationship between Alzheimer's disease and glaucoma remains poorly understood, and there are no studies investigating glaucoma in Mild Cognitive Impairment or mild AD.

Participant Demographics

Participants included individuals with Alzheimer's disease and age-matched controls, with a focus on older adults.

Digital Object Identifier (DOI)

10.4061/2010/793931

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication